Bridgeway Capital Management, LLC Actinium Pharmaceuticals, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.44 Billion
- Q3 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 77,000 shares of ATNM stock, worth $108,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,000
Previous 83,966
8.3%
Holding current value
$108,570
Previous $621,000
76.81%
% of portfolio
0.0%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding ATNM
# of Institutions
75Shares Held
8.32MCall Options Held
65.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY1.88MShares$2.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$2.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA686KShares$967,4750.0% of portfolio
-
State Street Corp Boston, MA603KShares$849,7350.0% of portfolio
-
Acadian Asset Management LLC Boston, MA454KShares$639,7080.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $35.5M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...